REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,503,692 | -30.1% | 59,411 | -11.1% | 1.81% | -39.3% |
| Q1 2023 | $2,152,433 | -35.5% | 66,825 | -63.0% | 2.98% | -6.9% |
| Q4 2022 | $3,334,873 | -35.6% | 180,654 | -5.8% | 3.20% | -35.7% |
| Q3 2022 | $5,180,000 | +179.4% | 191,868 | +43.0% | 4.98% | +146.8% |
| Q2 2022 | $1,854,000 | -46.1% | 134,188 | -23.9% | 2.02% | -15.5% |
| Q1 2022 | $3,439,000 | -15.2% | 176,336 | -29.0% | 2.39% | +22.7% |
| Q4 2021 | $4,056,000 | -12.9% | 248,533 | +48.7% | 1.95% | -5.8% |
| Q3 2021 | $4,658,000 | +1.6% | 167,191 | +8.1% | 2.07% | -2.3% |
| Q2 2021 | $4,586,000 | +9.4% | 154,715 | +3.1% | 2.12% | -14.7% |
| Q1 2021 | $4,193,000 | +65.6% | 150,013 | +67.9% | 2.48% | +28.4% |
| Q4 2020 | $2,532,000 | – | 89,348 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |